Centene raised its 2026 adjusted diluted EPS guidance floor to greater than $4.80, up from earlier expectations. The company said the increase reflects approximately $0.50 per share of non-recurring items in the Medicare and Commercial segments. In Medicare, the company cited favorable resolution of programmatic elements for the 2025 benefit year. The guidance update also reflects higher revenue expectations, with total revenue guidance lifted by $6 billion to a range of $193.5 billion to $197.5 billion, driven by premium tax revenue, Marketplace, and Medicaid.

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.